The X Prize is taking aim at aging with a new $101M award
technologyreview.com
technologyreview.com
"To win the competition, teams have to develop a “proactive, accessible therapeutic” that improves muscle, cognition, and immune function by an amount equivalent to a 10- to 20-year reduction in age in healthy people aged 65 to 80."
It's nice to have optimism, but the fact that the therapeutic has to be "proven" in healthy humans (not animal models) by 2030, makes this impossible.